AI assistant
Orchid Pharma Limited — Call Transcript 2026
Feb 6, 2026
60526_rns_2026-02-06_73cf6b32-17a3-49c5-8ef1-95101233cf00.pdf
Call Transcript
Open in viewerOpens in your device viewer
February 06, 2026
==> picture [552 x 66] intentionally omitted <==
National Stock Exchange of India Limited, BSE Limited Exchange Plaza, Bandra Kurla Complex Phiroze Jeejeebhoy Towers, Bandra (E), Mumbai- 400051 Dalal Street, Fort, Mumbai- 400001
Symbol: ORCHPHARMA Scrip Code: 524372
Ref: (i) Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015
(ii) SEBI Circular SEBI/HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026
Sub: Intimation of schedule of Analysts/ Investors Earning Call for the Quarter-III of F.Y. 2025-26 ended on December 31, 2025
Dear Sir/Madam,
In reference to the captioned subject and pursuant to Regulation 30 read with Sub-Para 15, Para A of Part A of Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, read with SEBI Master Circular No.HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026 and in continuation to our intimation dated February 06, 2026 regarding intimation of schedule of Board Meeting, this is to intimate that an Analysts/Investors Earning Call hosted by ‘Systematix Institutional Equities’ is scheduled to be held on Thursday, February 12, 2026 at 04:30 P.M. (IST) to discuss the financial performance/ financial results of the Company for the Quarter-III of Financial Year 2025-26, ended on December 31, 2025.
The aforesaid information will also be hosted on the Company’s website at www.orchidpharma.com
Note: The schedule may undergo change due to exigencies on the part of the Analysts/Investors/Company.
The invite of the Analysts/Investors Earnings Call is enclosed herewith.
You are requested to take the above intimation on record.
Thanking You, For Orchid Pharma Limited
MANISH Digitally signed by MANISH DHANUKA DHANUKA Date: 2026.02.06 15:15:58 +05'30' Manish Dhanuka Managing Director DIN No. 00238798
Encl.: as above
==> picture [519 x 12] intentionally omitted <==
Orchid Pharma Limited Regd. Office: Plot Nos. 121-128, 128A-133, 138-151, 159-164, SIDCO Industrial Estate, Alathur, Chengalpattu Dist.- 603110, Tamil Nadu, India Phone : (91)-44- 2744 4471/72/73 Email: [email protected] Website : www.orchidpharma.com CIN: L24222TN1992PLC022994
==> picture [183 x 51] intentionally omitted <==
SYSTEMATIX INSTITUTIONAL EQUITIES
Invites you to participate in
Q3FY26 Results Conference Call of
==> picture [131 x 43] intentionally omitted <==
Orchid Pharma Limited
On Thursday, 12[th] February 2026 at 4:30 PM (IST)
The management will be represented by
| Mr. Manish Dhanuka Mr. Mridul Dhanuka Mr. Sunil Kumar Gupta |
Mr. Manish Dhanuka Mr. Mridul Dhanuka Mr. Sunil Kumar Gupta |
|---|---|
| Managing Director Whole Time Director Chief Financial Officer |
|
| Dial-in-number | |
| Location Dial Number |
Location Toll Free Number |
| Primary Number +91 22 6280 1297 |
USA :1 866 746 2133 |
| UK :0 808 101 1573 |
|
| Secondary Number +91 22 7115 8198 |
Singapore :800 101 2045 |
| Hong Kong :800 964 448 |
Click here for your Diamond Pass™
https://services.choruscall.in/DiamondPassRegistration/register?confirmationNumber=3980269&linkSecurityString=200f2af07a DiamondPass™ is a Premium Service that enables you to connect to your conference call without having to wait for an operator.
For more information, please contact:
Vishal Manchanda
Equity Research Analyst Contact No: +91 97374 37148 [email protected]
Mrunal Pawar
VP & Group Head - Corporate Access & Corporate Communication Contact No: + 91 22 6704 8088 [email protected]